The first case of COVID-19 a coronavirus disease, was reported in December 2019 in
Wuhan, China, and spread globally. Severe acute respiratory syndrome coronavirus 2 …

Incorporating sensing and therapeutic capabilities into everyday textiles could be a powerful
approach in the development of personalized healthcare. The creation of such smart textiles …

Anosmia, the loss of smell, is a common and often the sole symptom of COVID-19. The onset
of the sequence of pathobiological events leading to olfactory dysfunction remains obscure …

The first two mRNA vaccines against infection by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) that were approved by regulators require a cold chain and …

Several neutralizing monoclonal antibodies (mAbs) to severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) have been developed and are now under evaluation in clinical …

Background: The impact of coronavirus disease 2019 (COVID-19) on maternal and newborn
health is unclear. We aimed to evaluate the association between severe acute respiratory …

Background Due to the national dynamic zero-COVID strategy in China, there were no
persistent local transmissions of SARS-CoV-2 in Beijing before December, 2022. However …

In the modern era, many terms related to artificial intelligence, machine learning, and deep
learning are widely used in domains such as business, healthcare, industries, and military …

COVID-19, caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2),
was declared a pandemic by the World Health Organization (WHO) on the 11th of March …

Three major outbreaks of the coronavirus, a zoonotic virus known to cause respiratory
disease, have been reported since 2002, including SARS-CoV, MERS-CoV and the most …